Urethra contours on MRI: multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarking
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
The urethra is a recommended avoidance structure for prostate cancer treatment. However, even subspecialist physicians often struggle to accurately identify the urethra on available imaging. Automated segmentation tools show promise, but a lack of reliable ground truth or appropriate evaluation standards has hindered validation and clinical adoption. This study aims to establish a reference-standard dataset with expert consensus contours, define clinically meaningful evaluation metrics, and assess the performance and generalizability of a deep-learning-based segmentation model.
Materials and Methods
A multidisciplinary panel of four experienced subspecialists in prostate MRI generated consensus contours of the male urethra for 71 patients across six imaging centers. Four of those cases were previously used in an international study (PURE-MRI), wherein 62 physicians attempted to contour the prostate and urethra on the patient images. Separately, we developed a deep-learning AI model for urethra segmentation using another 151 cases from one center and evaluated it against the consensus reference standard and compared to human performance using Dice Score, percent urethra Coverage, and Maximum 2D (axial, in-plane) Hausdorff Distance (HD) from the reference standard.
Results
In the PURE-MRI dataset, the AI model outperformed most physicians, achieving a median Dice of 0.41 (vs. 0.33 for physicians), Coverage of 81% (vs. 36%), and Max 2D HD of 1.8 mm (vs. 1.6 mm). In the larger dataset, performance remained consistent, with a Dice of 0.40, Coverage of 89%, and Max 2D HD of 2.0 mm, indicating strong generalizability across a broader patient population and more varied imaging conditions.
Conclusion
We established a multidisciplinary consensus benchmark for segmentation of the urethra. The deep-learning model performs comparably to specialist physicians and demonstrates consistent results across multiple institutions. It shows promise as a clinical decision-support tool for accurate and reliable urethra segmentation in prostate cancer radiotherapy planning and studies of dose-toxicity associations.
